Literature DB >> 12121568

Impact of obesity on hypogonadism in the andropause.

R S Tan1, S J Pu.   

Abstract

Obesity is an issue that is increasingly affecting ageing men. With ageing, there is a decline in androgens as well. There are implications for the health of ageing men as a result of hypogonadism. Overall, there seems to be an inverse relationship between body mass index and testosterone levels, as is also demonstrated in our cross-sectional study. Obesity seems to depress the production of testosterone. It has been hypothesized that there is increased aromatization of testosterone to oestradiol and alteration of the hypothalamic-pituitary-adrenal axis in obese older men. Some hormones can affect obesity in ageing men including leptin, insulin, dehydroepiandrostenedione and growth hormone. The relationship of obesity to these hormones in ageing men will be reviewed. Testosterone replacement in ageing men can alter body composition whereby fat is exchanged for muscle. These studies will also be reviewed. Further studies in this field are recommended to evaluate long-term benefits and risks.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121568     DOI: 10.1046/j.1365-2605.2002.00356.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  15 in total

Review 1.  [Diagnosis of the "aging male"--what is recommended?].

Authors:  V S Lenk
Journal:  Urologe A       Date:  2005-10       Impact factor: 0.639

2.  Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease.

Authors:  Emily R Rosario; Lilly Chang; Elizabeth H Head; Frank Z Stanczyk; Christian J Pike
Journal:  Neurobiol Aging       Date:  2009-05-09       Impact factor: 4.673

3.  The Effect of Testosterone Topical Solution in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel.

Authors:  Patrick R Burns; Edward D Kim; Dustin D Ruff; Allen D Seftel
Journal:  Am J Mens Health       Date:  2015-10-05

Review 4.  Testosterone supplementation therapy in the treatment of patients with metabolic syndrome.

Authors:  Jason R Kovac; Jason Kovac; Alexander W Pastuszak; Dolores J Lamb; Larry I Lipshultz
Journal:  Postgrad Med       Date:  2014-11       Impact factor: 3.840

5.  Hypogonadal men with type 2 diabetes mellitus have smaller bone size and lower bone turnover.

Authors:  Georgia Colleluori; Lina Aguirre; Richard Dorin; David Robbins; Dean Blevins; Yoann Barnouin; Rui Chen; Clifford Qualls; Dennis T Villareal; Reina Armamento-Villareal
Journal:  Bone       Date:  2017-03-16       Impact factor: 4.398

6.  Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?

Authors:  Antonio Aversa; Roberto Bruzziches; Davide Francomano; Marco Natali; Andrea Lenzi
Journal:  Ther Adv Urol       Date:  2009-10

Review 7.  The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health.

Authors:  Marià Alemany
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

Review 8.  Implications of adiponectin in linking metabolism to testicular function.

Authors:  Luc J Martin
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

9.  A novel mouse model of Alzheimer's disease with chronic estrogen deficiency leads to glial cell activation and hypertrophy.

Authors:  Annik Prat; Maik Behrendt; Edwige Marcinkiewicz; Sebastien Boridy; Ram M Sairam; Nabil G Seidah; Dusica Maysinger
Journal:  J Aging Res       Date:  2011-09-28

10.  Improvement of andropause symptoms by dandelion and rooibos extract complex CRS-10 in aging male.

Authors:  Yoo-Hun Noh; Do-Hee Kim; Joon Yub Kim; Jiae Park; Ok Hyeon Kim; Daeseok Han; Won-Yong Kim; Sung-Su Kim; Moo-Yeol Lee; Seok-Hyun Heo; Misook Kim; Won Bok Lee; Yoonhwa Jeong; Soon Chul Myung
Journal:  Nutr Res Pract       Date:  2012-12-31       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.